Newsroom
France
Isle sur la Sorgue
Industrial sovereignty in action!
4 Luglio 2025
At L'Isle-sur-la-Sorgue (ISS), we took up the challenge of re-internalising the packaging of softgels and capsules for our new range of dietary supplements:
Dreux
France
TeamMayoly in top form in Chartres, near our Dreux industrial site!
4 Luglio 2025
🔥 For the 30th anniversary of the Foulées de la Cathédrale, 60 Mayoly employees got their shirts wet under the sun :
[Seen in Les Echos] Committed companies in the spotlight!
3 Luglio 2025
Improving the health and well-being of patients and consumers has been part of our DNA since our creation, and drives our day-to-day actions. This is the conviction we shared during the round table “Finance, a vector of social transformation?” with Nicolas Giraud
China
Tianjin
📹 Video : Tianjin Happy to celebrate 10 years without incident
3 Luglio 2025
Congratulations to our teams for their commitment, discipline and team spirit ! 👏
Ukraine
🩺 Topicrem's Participation in the Dermatological Conference in Kyiv
3 Luglio 2025
👩⚕️ The Ukrainian Topicrem team actively participated in the event focused on skin cancer, its prevention and treatment methods.
Mayoly, co-winner of the Best ESG Initiative 2025 award.
27 Giugno 2025
We are proud to announce that Mayoly has been named co-winner of the Best ESG 2025 Initiative Award, and nominated in the “Best Progress” category at the Sustainability & Impact Awards organized by CAPZA!
Ukraine
Culture & Values Workshop at Mayoly Ukraine
26 Giugno 2025
This week, our team at Mayoly Ukraine came together for a powerful and inspiring workshop focused on our company’s core values.
Mexico
Recognize constantly
25 Giugno 2025
From Italy, we value feedback, which is key driver of progress, to grow, align, and move forward together.
Letter heads update
24 Giugno 2025
The new MAYOLY PHARMA FRANCE and MAYOLY INDUSTRIE letterheads, in both French and English, are now available on the intranet.
France
[New] Patient brochures on irritable bowel syndrome available in herbal tea shops
17 Giugno 2025
Irritable bowel syndrome (IBS) is a common digestive disorder, with multiple causes and manifestations that vary from person to person. Because it requires a holistic approach, integrating physical, emotional and behavioral dimensions, Global Pharma teams have developed a series of 4 educational brochures for patients.